GRIN2D and breast cancer: The increase in Ca2+ is considered to be central in the progression of breast cancer, and the miR-129-1-3p transfection of MDA-MB-231cells was followed by the decrease in intracellular Ca2+ and the activation of GRIN2D (Glutamate Ionotropic Receptor NMDA Type Subunit 2D), indicating that the miR-129-1-3p can suppress the development of TNBC by the regulation of MNDAR (105).